Clinical Trial Update: Atacicept in Multiple Glomerular Diseases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating atacicept in multiple glomerular diseases is currently recruiting, including primary membranous nephropathy, IgA nephropathy, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Segmental Glomerulosclerosis
• Iga Nephropathy
• Membranous Nephropathy
• Minimal Change Disease
• Nephrotic Syndrome

Drugs mentioned

• Atacicept (atacicept)

Snippet

Sponsor: Vera Therapeutics, Inc. | Conditions: pMN, IgAN | Phase 2 | Status: RECRUITING